Thus, studies with larger sample sizes and standardized quantitative measures of KI67 across studies are needed to evaluate the relationship between breast cancer risk factors and HR+ tumors defined by their levels of proliferation and histologic grade. Here, MKI67 is linked to breast carcinoma.